Skip to main content
. 2017 Jun 27;35(12):1211–1221. doi: 10.1007/s40273-017-0528-y

Table 6.

List of adjustments on company submission base case

No. Change on the company base case
1 Removal of programming errors (half cycle correction and docetaxel price calculations)
2 Weight/body surface area and treatment-specific hospital length of stay of patients based on region 1, not all patients in the trials
3 Correction of double counting for hospitalizations due to adverse events